CMS Considers Coverage For GE’s Risk-Predictor Tool For Sudden Cardiac Death
This article was originally published in The Gray Sheet
Executive Summary
The Medicare agency says it is reconsidering a 2008 national noncoverage policy for GE Healthcare’s microvolt T-Wave alternans testing tool for evaluating risk of sudden cardiac death, and the potential need for an ICD. An alternative MTWA technique is already covered, but the company that makes that product is going out of business.